Literature DB >> 25417928

Ketamine-an update on its clinical uses and abuses.

Jian Xu1, Hong Lei.   

Abstract

This review highlights the recent clinical research that supports the therapeutic utility of ketamine as a multifaceted drug. After long-term use as a dissociative anesthetic, it has re-emerged as a useful agent for ameliorating pain, asthmaticus, and depression. In addition, it is also a substance of abuse. Chronic ketamine abuse over prolonged periods (weeks, months, and years) can produce toxicity to the gastrointestinal and urinary tract. In this review, we described the recent progress on its clinical uses and abuses.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Abuse; Antidepressant; Asthmaticus; Ketamine

Mesh:

Substances:

Year:  2014        PMID: 25417928      PMCID: PMC6493134          DOI: 10.1111/cns.12363

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  5 in total

1.  New use for an old drug: oral ketamine for treatment-resistant depression.

Authors:  Kevin M Swiatek; Kim Jordan; Julie Coffman
Journal:  BMJ Case Rep       Date:  2016-08-03

Review 2.  Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.

Authors:  Faryal Mallick; Cheryl B McCullumsmith
Journal:  Curr Psychiatry Rep       Date:  2016-06       Impact factor: 5.285

Review 3.  Advances in novel molecular targets for antidepressants.

Authors:  Qingzhong Wang; Yogesh Dwivedi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-07-16       Impact factor: 5.067

4.  Difference in long-term relapse rates between youths with ketamine use and those with stimulants use.

Authors:  Liang-Jen Wang; Mei-Yen Chen; Chin-Yin Lin; Mian-Yoon Chong; Wen-Jiun Chou; Yu-Han You; Chih-Pu Tsai; Yi-Syuan Chen; Shing-Fang Lu
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-12-22

5.  A family-oriented treatment program for youths with ketamine abuse and their caregivers: a pilot study in Taiwan.

Authors:  Liang-Jen Wang; Shing-Fang Lu; Wen-Jiun Chou; Mian-Yoon Chong; Yao-Hsing Wang; Yu-Lian Hsieh; Yi-Hsuan Lee; Ching Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-31       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.